121 related articles for article (PubMed ID: 31652449)
1. Effects of the MAML2 genetic variants in glioma susceptibility and prognosis.
Zhang M; Zhao Y; Zhao J; Huang T; Guo X; Ma X; Wu Y
Biosci Rep; 2019 Oct; 39(10):. PubMed ID: 31652449
[TBL] [Abstract][Full Text] [Related]
2. Impact of ANXA5 polymorphisms on glioma risk and patient prognosis.
Guo X; Song J; Zhao J; Wang B; Yang Z; Sun P; Hu M
J Neurooncol; 2019 Mar; 142(1):11-26. PubMed ID: 30536196
[TBL] [Abstract][Full Text] [Related]
3. Impact of four lncRNA polymorphisms (rs2151280, rs7763881, rs1136410, and rs3787016) on glioma risk and prognosis: A case-control study.
Deng Y; Zhou L; Li N; Wang M; Yao L; Dong S; Zhang M; Yang P; Hao Q; Wu Y; Lyu L; Jin T; Dai Z; Kang H
Mol Carcinog; 2019 Dec; 58(12):2218-2229. PubMed ID: 31489712
[TBL] [Abstract][Full Text] [Related]
4. Genetic variants in MIR17HG affect the susceptibility and prognosis of glioma in a Chinese Han population.
Feng J; Ouyang Y; Xu D; He Q; Liu D; Fan X; Xu P; Mo Y
BMC Cancer; 2020 Oct; 20(1):976. PubMed ID: 33036577
[TBL] [Abstract][Full Text] [Related]
5. Impact of AKAP6 polymorphisms on Glioma susceptibility and prognosis.
Zhang M; Zhao Y; Zhao J; Huang T; Wu Y
BMC Neurol; 2019 Nov; 19(1):296. PubMed ID: 31759389
[TBL] [Abstract][Full Text] [Related]
6. Polymorphism in the IL4R gene and clinical features are associated with glioma prognosis: Analyses of case-cohort studies.
Jin TB; Du S; Zhu XK; Li G; Ouyang Y; He N; Zhang Z; Zhang Y; Kang L; Yuan D
Medicine (Baltimore); 2016 Aug; 95(31):e4231. PubMed ID: 27495027
[TBL] [Abstract][Full Text] [Related]
7. Genetic Variations of
Xi M; Zhang G; Wang L; Chen H; Gao L; Zhang L; Yang Z; Shi H
Pharmgenomics Pers Med; 2022; 15():487-497. PubMed ID: 35592549
[TBL] [Abstract][Full Text] [Related]
8. Variants in Notch signalling pathway genes, PSEN1 and MAML2, predict overall survival in Chinese patients with epithelial ovarian cancer.
Xu Y; Cheng L; Dai H; Zhang R; Wang M; Shi T; Sun M; Cheng X; Wei Q
J Cell Mol Med; 2018 Oct; 22(10):4975-4984. PubMed ID: 30055028
[TBL] [Abstract][Full Text] [Related]
9. Role of PVT1 polymorphisms in the glioma susceptibility and prognosis.
Ding X; Zhao Y; Yuan H; Zhang Y; Gao Y
Eur J Cancer Prev; 2021 Sep; 30(5):400-408. PubMed ID: 33443959
[TBL] [Abstract][Full Text] [Related]
10. The Impact of PPARD and PPARG Polymorphisms on Glioma Risk and Prognosis.
Ding X; Han X; Yuan H; Zhang Y; Gao Y
Sci Rep; 2020 Mar; 10(1):5140. PubMed ID: 32198386
[TBL] [Abstract][Full Text] [Related]
11. Effects of the functional HOTAIR rs920778 and rs12826786 genetic variants in glioma susceptibility and patient prognosis.
Xavier-Magalhães A; Oliveira AI; de Castro JV; Pojo M; Gonçalves CS; Lourenço T; Viana-Pereira M; Costa S; Linhares P; Vaz R; Nabiço R; Amorim J; Pinto AA; Reis RM; Costa BM
J Neurooncol; 2017 Mar; 132(1):27-34. PubMed ID: 28083786
[TBL] [Abstract][Full Text] [Related]
12. Genetic variant of MAML2 in the NOTCH signaling pathway and the risk of bladder cancer: A STROBE-compliant study.
Shen Y; Lu Q; Ye H; Deng Z; Ma L; Zhang Q; Tang J; Yuan L
Medicine (Baltimore); 2020 Jan; 99(2):e18725. PubMed ID: 31914088
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of Genetic Variants in MIR3142HG in Susceptibility to and Prognosis of Glioma.
Guo X; Zhang M; Li Q; Zhao J; Wang B; Wang J; Mao P; Song J
Am J Clin Oncol; 2020 Jan; 43(1):1-8. PubMed ID: 31513017
[TBL] [Abstract][Full Text] [Related]
14. A functional polymorphism in the pre-miR-146a gene is associated with risk and prognosis in adult glioma.
Permuth-Wey J; Thompson RC; Burton Nabors L; Olson JJ; Browning JE; Madden MH; Ann Chen Y; Egan KM
J Neurooncol; 2011 Dec; 105(3):639-46. PubMed ID: 21744077
[TBL] [Abstract][Full Text] [Related]
15. IL-10 and PRKDC polymorphisms are associated with glioma patient survival.
Hu M; Du J; Cui L; Huang T; Guo X; Zhao Y; Ma X; Jin T; Li G; Song J
Oncotarget; 2016 Dec; 7(49):80680-80687. PubMed ID: 27811370
[TBL] [Abstract][Full Text] [Related]
16. The Influence of NDRG1 Single Nucleotide Polymorphisms on Glioma Risk and Prognosis in Chinese Han Population.
Yang Y; Cheng Y; Yang L; Shi G; Chen P; Li L; Fang H; Chen C; Jin T
Cell Mol Neurobiol; 2022 Aug; 42(6):1949-1964. PubMed ID: 33709284
[TBL] [Abstract][Full Text] [Related]
17. Impact of TGF-β1 -509C/T and 869T/C polymorphisms on glioma risk and patient prognosis.
Vieira de Castro J; Gonçalves CS; Costa S; Linhares P; Vaz R; Nabiço R; Amorim J; Viana-Pereira M; Reis RM; Costa BM
Tumour Biol; 2015 Aug; 36(8):6525-32. PubMed ID: 25813152
[TBL] [Abstract][Full Text] [Related]
18. Effect of epidermal growth factor receptor gene polymorphisms on prognosis in glioma patients.
Li B; Zhao W; Li J; Yan M; Xie Z; Zhu Y; Chen C; Jin T
Oncotarget; 2016 Sep; 7(39):63054-63064. PubMed ID: 27437777
[TBL] [Abstract][Full Text] [Related]
19. ARRDC3 polymorphisms may affect the risk of glioma in Chinese Han.
Li N; Shi H; Hou P; Gao L; Shi Y; Mi W; Zhang G; Wang N; Dai W; Wei L; Jin T; Shi Y; Guo S
Funct Integr Genomics; 2022 Feb; 22(1):27-33. PubMed ID: 34748117
[TBL] [Abstract][Full Text] [Related]
20. Effect of OR51E1 single nucleotide polymorphisms on glioma susceptibility in the Chinese Han population.
Wei J; Zhang H; Ma X; Li Y; Zhou W; Guo J; Jin T; Hu M
Gene; 2023 Jul; 875():147489. PubMed ID: 37207826
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
